Evommune, Inc. (EVMN)
NYSE · Healthcare
Evommune, Inc. Revenue 2024–2025
Evommune, Inc. annual/quarterly revenue history and growth rate from 2024 to 2026. Revenue can be defined as the amount of money a company receives from its customers in exchange for the sale of goods or services. Revenue is the top line item on an income statement from which all costs and expenses are subtracted to arrive at net income.
- Evommune, Inc. revenue for the quarter ending March 31, 2026 was 0, a 100.00% decrease year-over-year.
- Evommune, Inc. annual revenue for 2025 was 13.0 M, a 85.71% increase from 2024.
- Evommune, Inc. annual revenue for 2024 was 7.0 M.
Revenue
ANNUAL · $B
QUARTERLY · $B
YEAR-OVER-YEAR GROWTH · %
Evommune, Inc. Market Cap — FAQ
Evommune, Inc. (EVMN) market cap over the last 2 years — annual and quarterly figures with year-over-year growth and charts.
Where can I see EVMN's market cap history?
The chart and table above show Evommune, Inc.'s market cap by year and by quarter, including the growth rate.